Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
CorMedix Inc. (NASDAQ: CRMD)
CRMD Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-32.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
87.30%
CRMD Stock Analysis
CRMD
PE Ratio:
4
CRMD
PEG Ratio:
-0.1
CRMD
Forward EPS Growth (12 month):
-36.70%
CRMD
PS Ratio:
1.6
CRMD
PSG Ratio:
-0.2
CRMD
Forward Revenue Growth (12 month):
-9.20%
CRMD Articles
No data was found